Day One Biopharmaceutical... (DAWN)

8.07

-0.12 (-1.47%)

At close: Mar 28, 2025, 3:59 PM

8.07

-0.06%

After-hours: Mar 28, 2025, 04:20 PM EDT

Day One Biopharmaceuticals Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19
Net Income	-95.5M	-188.92M	-142.18M	-72.75M	-43.84M	-16.98M
Depreciation & Amortization	1.56M	383K	531K	199K	155K	n/a
Stock-Based Compensation	48.26M	39.34M	27.24M	13.32M	526K	111K
Other Working Capital	n/a	7.1M	8.05M	1.15M	-489K	430K
Other Non-Cash Items	-32.44M	-7.08M	-2.03M	8M	30.03M	11.91M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	9.42M	6.56M	2.69M	-357K	444K
Operating Cash Flow	-78.11M	-146.85M	-109.87M	-48.54M	-13.49M	-4.51M
Capital Expenditures	-2.17M	-3.22M	-26K	-8M	-92K	n/a
Acquisitions	n/a	n/a	255.05K	n/a	n/a	n/a
Purchase of Investments	-658.62M	-443.84M	-394.21M	n/a	n/a	n/a
Sales Maturities Of Investments	393.89M	575.44M	139.16M	n/a	n/a	n/a
Other Investing Acitivies	35.9M	-3M	-255.05K	-8M	n/a	n/a
Investing Cash Flow	-230.99M	128.38M	-255.07M	-8M	-92K	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	1M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	25.11M	5.18M	4.29M	130.07M	29.98M	29.91M
Financial Cash Flow	203.29M	164M	165.9M	297.12M	29.98M	30.91M
Net Cash Flow	-105.82M	145.52M	-199.05M	240.58M	16.4M	26.39M
Free Cash Flow	-80.28M	-150.08M	-109.9M	-56.54M	-13.58M	-4.51M